Andere Sprachen Inspira Technologies Oxy B.H.N. Ltd.

Aktien

A3EZ7B

IL0011715781

IINN

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 07.05.2024			% 5 Tage	% 1. Jan.
2,21 ^USD	+0,45 %		+17,55 %	+108,49 %

02.05.	Inspira? kündigt Produktionsstart des Inspira? an Art100	CI
17.04.	Inspira Technologies OXY B.H.N. Ltd. unterzeichnet ein Kooperationsabkommen mit dem Beilinson-Krankenhaus in Israel zur Evaluierung des firmeneigenen INSPIRA ART100-Geräts bei Organtransplantationen	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Inspira? Announces Start of Production of the Inspira? Art100	02.05.
Inspira Technologies OXY B.H.N. Ltd Signs Collaboration Term Sheet with the Beilinson Hospital in Israel for the Evaluation of Its Proprietary INSPIRA ART100 device in Organ Transplant Procedures	17.04.
Inspira, Beilinson Hospital Collaborate on Organ Transplant Device Evaluation	16.04.
Inspira?? and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth Causes Bloodstream Infections	10.04.
Inspira? Technologies Oxy B.H.N. Ltd. Announces Program to Pioneer the Applicable Use of the INSPIRA? ART100 Device for an Artificial Womb	03.04.
Inspira Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager	02.04.
Inspira Technologies Reports Full Year 2023 Financial Results	26.03.
Inspira Technologies Oxy B.H.N. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25.03.
Inspira Technologies OXY B.H.N. Ltd. Announces AMAR Regulatory Submission of the INSPIRA? ART100, to Enter the Southeast Asia and South American Markets	18.03.
Inspira Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator	12.03.
INSPIRA TECHNOLOGIES OXY B H N : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	08.03.
INSPIRA TECHNOLOGIES OXY B H N : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	04.03.
Inspira Technologies Oxy B.H.N. Ltd. Plans to Report the Primary Results for A Core Blood Oxygenation Technology Within Days	04.03.
Inspira Announces Breakthrough Update, Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements	28.02.
Inspira to Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone	28.02.
Inspira Technologies Oxy B.H.N. Ltd. Announces Approval from the U.S. Food & Drug Administration for its INSPIRA ART100 in the First Half of 2024	27.02.
Inspira Technologies OXY B.H.N. Ltd. Introduces High-End Platform for Bio-Mimicking Blood parameters for Development and Testing of Core Technologies	22.02.
Inspira Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System	15.02.
Sector Update: Health Care Stocks Gain Late Afternoon	14.02.
Sector Update: Health Care Stocks Rise in Afternoon Trading	14.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Inspira Technologies Oxy B.H.N. Ltd.

Aktien

A3EZ7B

IL0011715781

IINN

Andere Sprachen

Filter